97036 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Immunoglobulin superfamily CD58
BISPECIFIC ANTIBODY FUSION MOLECULES AND METHODS OF USE THEREOF
#2LFA3 VARIANTS AND COMPOSITIONS AND USES THEREOF
#3VIRAL PARTICLE WITH SURFACE STIMULATING MOLECULES
#4COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE
#5POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE
#6ALLOREACTIVE IMMUNE CELL-DISTANCING DEVICE AND USES THEREOF FOR PROTECTING DONOR-DERIVED CELLS FROM ALLOREJECTION
#7COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE
#8Variant CD58 domains and uses thereof
#9METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY
#10Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use
#11Compositions and methods for enhancing the stability of transgenes in poxviruses
#12Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions
#13Compositions and methods for enhancing the stability of transgenes in poxviruses
#14Alteration of Fc-fusion protein serum half-lives by mutagenesis
#15Modified KSA and Uses Thereof
#16Recombinant vector expressing multiple costimulatory molecules and uses thereof
#17Alteration of Fc-fusion protein serum half-lives by mutagenesis
#18Fused Protein Composition
#19Haplotype Markers And Methods Of Using The Same To Determine Response To Treatment
#20Methods of treating viral disorders
#21Methods of treating skin disorders
#22Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
#23Alteration of Fc-fusion protein serum half-lives by mutagenesis